Delivery Order SPE2D021D0005-SPE2D324F144D
Award Date
7/23/24
Potential Completion Date
7/26/24
Potential Value
$3.3K
Federal Agency
Medical Supply Chain
Awardee
Genentech Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc. for the pharmaceutical product Activase (alteplase). The $3,256.83 firm-fixed-price contract has an ultimate completion date of August 12, 2024. Genentech, a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics, has provided a range of medical products to federal agencies including the Departments of Defense, Health and Human Services, Justice, and Veterans Affairs. Genentech holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology company that manufactures pharmaceuticals. The contract is for the delivery of 50 mg vials of the drug Activase (alteplase), which is used to treat ischemic stroke. The award has a ceiling value of $3,256.83 and a period of performance through July 26, 2024. Genentech has multiple contract vehicles with the federal government, including a $4.9 billion Federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The $872,420.96 firm fixed-price contract is for the provision of various medical supplies and pharmaceuticals, including critical medications such as Tamiflu, Activase, TNKase, and Xofluza, as well as routine medications like clonazepam and diazepam tablets. The contract has an ultimate completion date of June 22,...
The Defense Logistics Agency Troop Support Medical awarded a $343,886.48 firm fixed-price delivery order contract to Genentech USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer. This order is placed under an existing contract vehicle and supports the agency's requirement for pharmaceutical products. Genentech holds various indefinite delivery contracts and Federal Supply Schedule agreements with government agencies, allowing them to efficiently procure vital medicines like the...
This is a delivery order (SPE2DP16D0008|0041) awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals. The $9,862,682.40 firm-fixed-price contract is for the delivery of oseltamivir phosphate, an antiviral medication, to support the federal government's medical supply needs. The contract does not have a set-aside designation. Genentech holds several key contract vehicles with federal...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,713.85 contract is for the delivery of 100mg vials of the drug Activase. This is an "off-the-shelf" pharmaceutical product purchase, with no set-aside designation. The award is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,330.62 firm fixed-price contract is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a completion date of June 24, 2025. The contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award is for the delivery of Activase 100 mg vials to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $31,745.75 contract is for the supply of Activase 100 mg vials, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. The award is associated with a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This is a $23,743.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,228,805 units of ACTIVASE 50 MG VIALS, a medical product, with a period of performance through May 14, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop...